Health Law Daily
A complete, daily report of breaking news in health law.
Breaking news and expert analysis on health law and compliance developments
What good is the right knowledge if it’s at the wrong time?
A complete daily report of the news that affects your world
- View full summaries of federal and state court decisions
- Access full text of legislative and regulatory developments
- Customize your daily email by topic and/or jurisdiction
- Search archives for stories of interest
Not just news – the right news
- Get expert analysis written by subject matter specialists—created by attorneys for attorneys
- Track law firms and organizations in the headlines with our new “Who’s in the News” feature
- Promote your firm with our permissions policy
24/7 access for a 24/7 world
- Forward information with special copyright permissions, encouraging collaboration between counsel and colleagues
- Save time with mobile apps for your iPhone, iPad, or Android
- Access all links from any mobile device without being prompted for user name and password
U.S. Supreme Court hears $12 billion ACA argument from insurers
Are health insurers entitled to recoup losses under the Obamacare "risk corridor" provision?
Patient’s claim against IVC filter maker time-barred under Wisconsin’s three-year statute of limitations
Pain and failed attempts to remove device were sufficient to put patient on notice of probable claim against the manufacturer in 2010.
Medical records provider did not have duty not to overcharge patients
Named plaintiffs in a class action suit against medical records provider Ciox could not prove elements of common-law claims styled as HIPPA claims, and Tennessee law does not apply to medical records...
Appeals court affirms decision, Final Medicaid Payment Rule is invalid
Where a statute’s language carries a plain meaning, the duty of the agency is to follow its commands as written and not to supplement those commands with others it may prefer.
Local retail stores not liable for selling sexual enhancement pills
Local retail stores that sell male enhancement drugs, without independently advertising the products, cannot held liable under the Lanham Act for false advertising.